The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2023

Filed:

Mar. 09, 2022
Applicant:

Molecular Partners Ag, Schlieren, CH;

Inventors:

Nina Reschke, Schlieren, CH;

Sebastian Grimm, Schlieren, CH;

Christian Reichen, Schlieren, CH;

Bernd Schlereth, Schlieren, CH;

Victor Levitsky, Schlieren, CH;

Matteo Bianchi, Schlieren, CH;

Assignee:

MOLECULAR PARTNERS AG, Schlieren, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2809 (2013.01); A61P 35/00 (2018.01); C07K 16/28 (2013.01); C07K 16/2803 (2013.01); C07K 16/2866 (2013.01); C07K 16/2875 (2013.01); C07K 2317/31 (2013.01); C07K 2318/00 (2013.01); C07K 2319/00 (2013.01);
Abstract

The present invention relates to recombinant multi-specific proteins comprising binding agents with binding specificity for different targets, such as, e.g. CD3, CD33, CD123 and CD70. In addition, the invention relates to nucleic acids encoding such multi-specific proteins, pharmaceutical compositions comprising such proteins or nucleic acids, and the use of such binding proteins, nucleic acids or pharmaceutical compositions in methods for treating or diagnosing diseases, such as cancer, e.g. acute myeloid leukaemia (AML), in a mammal, including a human.


Find Patent Forward Citations

Loading…